News
HC Wainwright & Co. Reiterates Buy on LAVA Therapeutics, Maintains $6 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
LAVA Therapeutics Q4 EPS $(0.24) Misses $(0.12) Estimate, Sales $353.00K Miss $6.25M Estimate
20 Mar 24
Earnings, News
LAVA Therapeutics N.V Filed U.S. Patent Application #20240067726-A1 For "Single Domain Antibodies Targeting CD1D"
29 Feb 24
Biotech, News, General
Press releases
Thinking about buying stock in Beyondspring, LAVA Therapeutics, Unicycive Therapeutics, Guardforce AI, or Infobird?
6 Mar 24
Opinion, Press Releases
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
5 Mar 24
Biotech, Press Releases, General
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
5 Mar 24
Press Releases, General
Thinking about buying stock in Societal CDMO, LAVA Therapeutics, Eastman Kodak, Brightspring Health Services, or Codexis?
1 Mar 24
Opinion, Press Releases
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
29 Jan 24
News, Press Releases